← Back to Clinical Trials
Recruiting NCT06876857

University of Central Florida CereBank

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Biospecimen Donation
Sponsor University of Central Florida
Study Type OBSERVATIONAL
Phase N/A
Enrollment 50,000
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2025-02-25
Completion 2075-02-25

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Millions of persons are affected by brain diseases. The CereBank will be used to support research studies aimed at improving the diagnosis and treatment of brain diseases. Brain diseases can be inherited; developed due to diseases or aging; or can be due to trauma. The Central Florida does not have a brain biobank to meet the needs of research. Therefore, it is necessary for the University of Central Florida to establish a brain biobank.

Eligibility Criteria

Inclusion Criteria: * Be 18 years or older. * Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent. Exclusion Criteria: * minors (under age 18). * prisoners. * pregnant women.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE BIOSPECIMEN DONATION TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}